arcoris bio is a startup based in Switzerland, most recent round Seed, 2 tracked investors.
Based in Switzerland, arcoris bio is a startup. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
arcoris bio develops the MUSE® nanotechnology platform for biomarker detection and signal amplification, enabling simultaneous detection of multiple biomarkers with high sensitivity and ease of use across various applications including immunofluorescence, immunohistochemistry, and in situ hybridization.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.